Bafna Pharmaceuticals
₹104.8
-4.85 (-4.42%)
09 May, 2024 15:34 BSE: 532989
NSE: BAFNAPHISIN: INE878I01022
Start SIP in Bafna Pharmaceuticals
Start SIPBafna Pharmaceuticals Performance
Day Range
- Low 104
- High 113
52 Week Range
- Low 76
- High 124
- Open Price113
- Previous Close110
- Volume20203
Bafna Pharmaceuticals Financials
| Indicator | Dec 2023 | Sep 2023 | Jun 2023 | Mar 2023 |
|---|---|---|---|---|
| Oper Rev Qtr Cr | 28 | 41 | 42 | 42 |
| Operating Expenses Qtr Cr | 31 | 37 | 36 | 35 |
| Operating Profit Qtr Cr | -2 | 4 | 6 | 8 |
| Depreciation Qtr Cr | 1 | 1 | 1 | 2 |
| Interest Qtr Cr | 1 | 0 | 1 | 1 |
| Tax Qtr Cr | 0 | 0 | 0 | 0 |
| Net Profit Qtr Cr | -3 | 2 | 6 | 5 |
Bafna Pharmaceuticals Technicals
EMA & SMA
Current Price
₹104.8
-4.85 (-4.42%)
- Bullish Moving Average
- ___
- 16
- Bearish Moving Average
- ___
- 0
- 20 Day
- ₹93.19
- 50 Day
- ₹90.39
- 100 Day
- ₹90.82
- 200 Day
- ₹92.64
- 20 Day
- ₹91.34
- 50 Day
- ₹87.54
- 100 Day
- ₹92.68
- 200 Day
- ₹91.98
Bafna Pharmaceuticals Resistance and Support
PIVOT
₹107.34
| Resistance | |
|---|---|
| First Resistance | 110.47 |
| Second Resistance | 116.13 |
| Third Resistance | 119.27 |
| RSI | 69.54 |
| MFI | 83.35 |
| MACD Single Line | 2.24 |
| MACD | 4.52 |
| Support | |
|---|---|
| First Resistance | 101.67 |
| Second Resistance | 98.53 |
| Third Resistance | 92.87 |
Bafna Pharmaceuticals Delivery and Volume
| Period | NSE + BSE Volume Avg | NSE + BSE Delivery Volume Avg | NSE + BSE Delivery Volume % |
|---|---|---|---|
| Day | 22,539 | 2,253,900 | 100 |
| Week | 35,978 | 3,597,800 | 100 |
| 1 Month | 12,543 | 1,254,294 | 100 |
| 6 Month | 12,256 | 1,225,636 | 100 |
Bafna Pharmaceuticals Result Highlights
Bafna Pharmaceuticals Synopsis
NSE-Medical-Generic Drugs
Bafna Pharmaceutical belongs to the Industry of Pharmaceuticals. Company’s Total Operating Revenue is Rs. 115.35 Cr. and Equity Capital is Rs. 23.66 Cr. for the Year ended 31/03/2023. Bafna Pharmaceuticals Ltd. is a Public Limited Listed company incorporated on 28/03/1995 and has its registered office in the State of Tamil Nadu, India. Company’s Corporate Identification Number(CIN) is L24294TN1995PLC030698 and registration number is 030698.| Market Cap | 248 |
| Sales | 153 |
| Shares in Float | 0.28 |
| No of funds | |
| Yield |
| Book Value | 3.38 |
| U/D Vol ratio | 1.5 |
| LTDebt / Equity | 11 |
| Alpha | 0.02 |
| Beta | 0.32 |
Bafna Pharmaceuticals
| Owner Name | Mar-24 | Dec-23 | Sep-23 | Jun-23 |
|---|---|---|---|---|
| Promoters | 88.3% | 88.43% | 88.74% | 90% |
| Individual Investors | 7.47% | 7.66% | 6.87% | 5.64% |
| Others | 4.23% | 3.91% | 4.39% | 4.36% |
Bafna Pharmaceuticals Management
| Name | Designation |
|---|---|
| Mrs. S Hemalatha | Chairperson & Executive Director |
| Mrs. Akila C Raju | Non Exe.Non Ind.Director |
| Ms. R Chitra | Ind. Non-Executive Director |
| Mr. B Kamlesh Kumar | Ind. Non-Executive Director |
| Mr. P K Sundaresan | Ind. Non-Executive Director |
Bafna Pharmaceuticals Forecast
Price Estimates
2,000(9.8%)
1,758(-3.5%)
1,590(-12.7%)
Bafna Pharmaceuticals Corporate Action
| Date | Purpose | Remarks |
|---|---|---|
| 2024-02-12 | Quarterly Results | |
| 2023-11-09 | Quarterly Results | |
| 2023-08-11 | Quarterly Results | |
| 2023-05-27 | Audited Results | (Revised) |
| 2023-04-07 | Others |
Bafna Pharmaceuticals FAQs
What is Share Price of Bafna Pharmaceuticals ?
Bafna Pharmaceuticals share price is ₹104 As on 09 May, 2024 | 15:20
What is the Market Cap of Bafna Pharmaceuticals ?
The Market Cap of Bafna Pharmaceuticals is ₹247.9 Cr As on 09 May, 2024 | 15:20
What is the P/E ratio of Bafna Pharmaceuticals ?
The P/E ratio of Bafna Pharmaceuticals is 22 As on 09 May, 2024 | 15:20
What is the PB ratio of Bafna Pharmaceuticals ?
The PB ratio of Bafna Pharmaceuticals is 3.4 As on 09 May, 2024 | 15:20